Tagged Articles

chromium 102 articles

DePuy seeks to overturn $8.26 million jury award in first ASR hip trial

Johnson & Johnson and its orthopedics unit DePuy seek to overturn a Los Angeles jury’s decision to award $8.26 million to a plaintiff for injuries he received from a metal-on-metal DePuy ASR hip implant. The companies claim that the jury’s findings were inconsistent with court instructions about defective product design and adequate warning of the device’s risk. The verdict DePuy and its parent company want to overturn concluded the first U.S. trial involving defective ASR hip implants. Plaintiff Loren Kransky sued DePuy and affiliated companies after the ASR device he had implanted in his left hip in 2007 failed and ... Read More

Researchers unsure how to evaluate metal ion levels in patients with metal-on-metal hip implants

Blood tests to measure the amount of metal ions in the blood of patients with metal-on-metal hip implants are inexpensive and provide helpful information. But they do not provide definitive information whether an artificial hip is functioning poorly and is likely to fail, new research shows. Chromium and cobalt ion levels are generally elevated in the blood of patients with all-metal hip implants. Because the implants have been found more likely to fail than traditional hip implants, medical regulators say that patients with the devices should be monitored on a regular basis for signs of failure. That monitoring generally includes a ... Read More

DePuy’s ASR hip implant caused plaintiff’s bone decay, surgeon tells jury

An orthopedic surgeon testifying on behalf of a woman who alleges she was injured by ASR metal hip implants manufactured by DePuy Orthopedics told jurors in the Circuit Court of Cook County, Illinois, that metal debris from the hip devices “absolutely” caused the plaintiff to suffer from bone decay. DePuy is a subsidiary of Johnson & Johnson. Surgeon Tony Nargol, who has warned about the dangers of metal-on-metal hip implants such as DePuy’s ASR devices, particularly to women, told jurors that plaintiff Carol Strum’s calcar bone had been “eaten away” near the ASR hip device she had implanted in in ... Read More

DePuy’s tests on metal artificial hip system failed to show potential dangers of device

Orthopedic doctors were optimistic when metal-on-metal hip replacement systems were first introduced around the world. They offered a seemingly more durable alternative to traditional ceramic or plastic artificial hips. The devices were especially attractive to younger recipients, who wanted to go back to a more active lifestyle. DePuy Orthopaedics, a subsidiary of Johnson & Johnson, introduced the DePuy ASR metal-on-metal hip replacement system and hip resurfacing system. The hip replacement system was quickly approved in the United States without prior human testing because it was similar to devices already on the market. However, the Food and Drug Administration (FDA) refused to ... Read More

Hip implant failure 29 percent higher in women, new study finds

A new study of more than 35,100 patients who were surgically implanted with artificial hip devices reveals that women are much more likely than men to require revision surgery within the first three years to correct problems with the implant. The research, published in JAMA Internal Medicine, was funded by the U.S. Food and Drug Administration (FDA) and comes amid a torrent of lawsuits against Johnson & Johnson and its orthopedic device unit DePuy alleging the company’s ASR all-metal hip devices caused serious, sometimes catastrophic, injuries in patients. Of the 35,140 total hip anthroplasty (THA) patients studied, female subjects were ... Read More

Emails presented in DePuy trial show marketer’s concerns over ASR hip implant safety

Internal communications among DePuy executives discussing how to handle metal-on-metal ASR hip problems were presented to jurors hearing the first of several thousand personal-injury lawsuits involving the faulty devices to go to trial. DePuy is a subsidiary of Johnson & Johnson. According to the records presented, on September 18, 2009, Paul Berman, DePuy’s director of hip marketing, sent one of many emails to company officials warning that the metal-on-metal hip devices should be recalled given the alarming number of reports that the devices were failing. Mr. Berman wrote that he wanted to “reiterate my concerns” about the safety of the ... Read More

Testimony in first DePuy trial indicates company failed to act on ASR hip warnings

Court documents and the recent testimony given by DePuy officials during the first ASR metal hip case to go to trial indicate the company took very little action, if any, to warn prospective patients about the serious risks its all-metal hip implants posed. DePuy Orthopedics, a division of the Johnson & Johnson health care conglomerate, started selling its ASR Acetabular and Hip Resurfacing Systems in 2003 after the devices were fast-tracked through the U.S. Food and Drug Administration’s approval process. By 2005, DePuy began receiving complaints about the all-metal devices, which were designed to outlast conventional hip implants made with ... Read More

First DePuy hip trial underway in Los Angeles

The first of several thousand personal-injury lawsuits accusing Johnson & Johnson of knowingly making and selling faulty metal-on-metal hip implants commenced Friday in California Superior Court in Los Angeles. Plaintiff Loren Kransky, a former North Dakota prison guard, received metal-on-metal hip implants made by Johnson & Johnson’s DePuy Orthopedics division in 2007 to relieve arthritis pain. But not long afterward, Mr. Kransky, 64, began experiencing many of the complications reported by others who received DePuy ASR implants: pain, swelling, difficulty walking, and a number of symptoms related to metal poisoning. On the first day of the trial, the plaintiff’s lawyer ... Read More

DePuy continued to make and sell faulty metal hip implants for months before recall

DePuy Orthopedics and its parent company Johnson & Johnson knew in 2008 its ASR metal hip implants were failing early at unusually high rates, but they continued to make the devices for several more months before finally recalling them in August 2010, newly released court documents show. The findings were contained in a number of pretrial depositions and internal company records unsealed before the scheduled start of the first trial over DePuy’s faulty implants on Friday. The case, which will be tried in California Superior Court in Los Angeles under Judge J. Stephen Czuleger. The trial will likely reveal a ... Read More

Court documents show DePuy knew nearly 40 percent of its hip implants failed within 5 years

Documents unsealed ahead of the first faulty hip implant lawsuit against Johnson & Johnson and DePuy Orthopedics to go to trial show that company executives knew in 2011 that its ASR metal hip implants would fail in nearly 40 percent of patients within five years, but withheld that information. DePuy, a division of medical giant Johnson & Johnson, recalled its ASR XL Acetabular and ASR Hip Resurfacing Systems in August 2010 as evidence mounted that the hip devices, which consisted of a metal ball and metal cup, failed at unusually high rates. At the time of the recall, the devices ... Read More